Everolimus-Eluting Coronary Stent Frame - Vietnam Registration 2403502ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Everolimus-Eluting Coronary Stent Frame in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TBYT Loại D medical device is registered under number 2403502ĐKLH/BYT-HTTB and manufactured by Nano Therapeutics Pvt. Ltd. The authorized representative in Vietnam is CÔNG TY CỔ PHẦN ĐẦU TƯ PHÁT TRIỂN TMT VIỆT NAM.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Theo theo phụ lục, and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2403502ĐKLH/BYT-HTTB
000.00.04.G18-231026-0009
Evermax
EM2.0008; EM2.0012; EM2.0016; EM2.0020; EM2.0024; EM2.0028; EM2.0032; EM2.0036; EM2.0040; EM2.0044; EM2.0048; EM2.0050; EM2.0052; EM2.2508; EM2.2512; EM2.2516; EM2.2520; EM2.2524; EM2.2528; EM2.2532; EM2.2536; EM2.2540; EM2.2544; EM2.2548; EM2.2550; EM2.2552; EM2.5008; EM2.5012; EM2.5016; EM2.5020; EM2.5024; EM2.5028; EM2.5032; EM2.5036; EM2.5040; EM2.5044; EM2.5048; EM2.5050; EM2.5052; EM2.7508; EM2.7512; EM2.7516; EM2.7520; EM2.7524; EM2.7528; EM2.7532; EM2.7536; EM2.7540; EM2.7544; EM2.7548; EM2.7550; EM2.7552; EM3.0008; EM3.0012; EM3.0016; EM3.0020; EM3.0024; EM3.0028; EM3.0032; EM3.0036; EM3.0040; EM3.0044; EM3.0048; EM3.0050; EM3.0052; EM3.5008; EM3.5012; EM3.5016; EM3.5020; EM3.5024; EM3.5028; EM3.5032; EM3.5036; EM3.5040; EM3.5044; EM3.5048; EM3.5050; EM3.5052; EM3.7508; EM3.7512; EM3.7516; EM3.7520; EM3.7524; EM3.7528; EM3.7532; EM3.7536; EM3.7540; EM3.7544; EM3.7548; EM3.7550; EM3.7552; EM4.0008; EM4.0012; EM4.0016; EM4.0020; EM4.0024; EM4.0028; EM4.0032; EM4.0036; EM4.0040; EM4.0044; EM4.0048; EM4.0050; EM4.0052; EM4.5008; EM4.5012; EM4.5016; EM4.5020; EM4.5024; EM4.5028; EM4.5032; EM4.5036; EM4.5040; EM4.5044; EM4.5048; EM4.5050; EM4.5052.
Technical Details
The Everolimus-coated Evermax stent is indicated for the treatment of patients who are candidates for percutaneous coronary intervention (PCI). The Everolimus-coated Evermax stent is indicated to improve the coronary artery diameter in patients with symptomatic ischemia due to chronic total occlusions (CTO) of the coronary arteries with a length ≤ 52 mm and a vessel diameter ranging from 2.00 to 4.50 mm, and who are candidates for percutaneous coronary intervention (PCI).
Dates and Status
Nov 14, 2024